A. Courdi
Papers
2
Total Citations
33
H-Index
2
About
A. Courdi is a pioneering radiation oncologist whose research has centered on the application of robotic stereotactic radioablation in breast cancer treatment. His major contributions lie in integrating this advanced, high-precision radiation technique with neo-adjuvant chemotherapy and as a boost therapy for early-stage disease. Courdi’s landmark 2009 study, "Robotic Stereotactic Radioablation Concomitant With Neo-Adjuvant Chemotherapy for Breast Tumors," with 30 citations, demonstrated the feasibility and safety of combining these modalities, offering a less invasive alternative to traditional surgery. He further advanced the field with a Phase 2 trial (2018) exploring robotic stereotactic boost in early breast cancer, refining dose delivery to improve tumor control while minimizing toxicity. Though his citation counts are modest, Courdi’s work is notable for its forward-looking, translational approach—bridging cutting-edge technology with clinical practice. His research has helped lay the groundwork for non-surgical breast cancer management, influencing subsequent studies on stereotactic body radiation therapy (SBRT) in oncology. For students and researchers, Courdi exemplifies how focused, innovative clinical trials can shape the future of cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic Stereotactic Boost in Early Breast Cancer, a Phase 2 Trial3 citations · 2018